Lorenzo Tua

ORCID: 0000-0003-0228-8290
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Cardiac Structural Anomalies and Repair
  • Acute Ischemic Stroke Management
  • Pulmonary Hypertension Research and Treatments
  • Acute Myocardial Infarction Research
  • Cardiovascular Function and Risk Factors
  • Lipoproteins and Cardiovascular Health
  • Cardiac pacing and defibrillation studies
  • Heart Failure Treatment and Management
  • Infective Endocarditis Diagnosis and Management
  • Patient Satisfaction in Healthcare
  • Diabetes Treatment and Management
  • Healthcare Quality and Management
  • Transplantation: Methods and Outcomes
  • Potassium and Related Disorders
  • Coronary Interventions and Diagnostics
  • Cardiomyopathy and Myosin Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Central Venous Catheters and Hemodialysis
  • Cardiac Arrest and Resuscitation
  • Emergency and Acute Care Studies

University of Pavia
2021-2024

All Saints Hospital
2024

Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
2024

Ospedale San Carlo
2024

Istituti di Ricovero e Cura a Carattere Scientifico
2021-2023

IRCCS Policlinico San Donato
2023

E Ink (South Korea)
2022

Policlinico San Matteo Fondazione
2021-2022

Abstract Background The incidence and predictors of 30‐day stroke after transcatheter aortic valve replacement (TAVR) were derived from early studies investigating first‐generation devices. 6‐month its related are unknown. Aims To investigate the to identify procedural patient‐related TAVR. Methods Data 2753 consecutive patients with severe stenosis undergoing TAVR obtained OBSERVANT‐II study, an observational, prospective, multicenter cohort study. study endpoints symptomatic Results...

10.1002/ccd.30848 article EN cc-by-nc-nd Catheterization and Cardiovascular Interventions 2023-10-04

Transcatheter edge-to-edge repair (TEER) with the MitraClip system (Abbott; Menlo Park, California, USA) represents a therapeutic option for functional mitral regurgitation (FMR) by reducing symptoms and improving clinical outcomes in selected patients.1, 2 In chronic MR, long-standing volume overload left-sided chambers leads to development of pulmonary hypertension (PH).3 The right ventricle (RV) initially responds increased afterload remodelling enlargement, but eventually ventricular...

10.1111/eci.13869 article EN cc-by-nc-nd European Journal of Clinical Investigation 2022-09-09

Abstract Aims Using the principles of clinical governance, a patient-centred approach intended to promote holistic quality improvement, we designed prospective, multicentre study in patients with acute coronary syndrome (ACS). We aimed verify and quantify consecutive inclusion describe relative absolute effects indicators for diagnosis therapy. Methods results Administrative codes invasive angiography myocardial infarction were used estimate ACS universe. The ratio between number included...

10.1093/ehjacc/zuac106 article EN cc-by-nc European Heart Journal Acute Cardiovascular Care 2022-09-19

Abstract Background Antithrombotic therapy in acute patients with both high ischaemic and bleeding risks remains challenging. Case summary We presented a challenging case involving 48-year-old man referred to our hospital for headache left superior quadrantanopia. A CT scan revealed right inferior occipital lobe stroke. During the stay, developed pulmonary embolism (PE), ST-elevation myocardial infarction (STEMI). triple antithrombotic was indicated, but patient (anaemia, active malignancy,...

10.1093/ehjcr/ytae066 article EN cc-by European Heart Journal - Case Reports 2024-01-30

Abstract Background Catheter-based revascularization procedures have been developed as an alternative to systemic thrombolysis or surgical embolectomy for intermediate-high and high risk pulmonary embolism (PE) patients with. Little is known about the outcomes of oncological patients, who are notably at higher bleeding risk, undergoing such procedure. Purpose The USAT IH-PE registry a retrospective prospective multicenter treated with ultrasound-facilitated, catheter-directed thrombolysis....

10.1093/eurheartj/ehae666.2196 article EN European Heart Journal 2024-10-01

Patients undergoing transcatheter aortic valve replacement (TAVR) have a concomitant indication for oral anticoagulation (OAC) in about 20 to 50% of the cases, mostly atrial fibrillation (AF).[1] However, it is still unclear whether direct anticoagulants (DOACs) or vitamin K antagonists (VKAs) should be favored this setting.

10.1055/s-0042-1760128 article EN Thrombosis and Haemostasis 2022-12-30

Abstract Background Many ST-segment elevation acute coronary syndrome (STEACS) patients fail to activate the Emergency Medical System (EMS), with possible dramatic consequences. Prior studies focusing on barriers EMS activation include any (ACS) without representation of southern European populations. However, are influenced by ACS type and socio-demographic racial factors. Purpose We aimed investigate call for diagnosed STEACS in Italy. Methods A prospective, single-center, survey-based...

10.1093/eurheartj/ehab724.1506 article EN European Heart Journal 2021-10-01

Abstract Background Several patients undergoing transcatheter aortic valve replacement (TAVR) also require oral anticoagulation (OAC) for atrial fibrillation (AF) or deep vein thromboembolism. However, the optimal type of OAC strategy (direct anticoagulants, DOACs, vitamin K antagonists, VKA) is still unclear in this setting. Method We performed systematic literature research and meta-analysis PubMed, Medline, EMBASE databases studies reporting either all-cause mortality,...

10.1093/eurheartjsupp/suac121.355 article EN European Heart Journal Supplements 2022-12-14

Abstract Funding Acknowledgements Type of funding sources: None. Background and purpose Permanent pacemaker implantation (PPMi) is needed in about 5% patients following heart transplant (HTx) primarily due to sinus node dysfunction (SND), which commonly occurs an early phase, or atrio-ventricular block (ABV), common later on. Currently, data on rate ventricular pacing (VP) lacking little known long-term outcomes after PPMi. Methods This was a retrospective, monocentric study. Among 1123...

10.1093/europace/euab116.393 article EN EP Europace 2021-05-01

Abstract Background Sodium-glucose transporter 2 inhibitors (SGLT2-i) have demonstrated substantial improvement in clinical outcomes for patients with heart failure (HF) and chronic kidney disease (CKD) or without diabetes mellitus (DM). Prescription patterns outcome of SGLT2-i candidates hospitalized an acute coronary syndrome (ACS) are less well established. Purpose We aimed to assess the proportion characterize their a contemporary, prospective, multicenter, quality-improvement study...

10.1093/eurheartj/ehab724.1211 article EN European Heart Journal 2021-10-01

Introduction: Postoperative atrial fibrillation (POAF) is a frequently reported complication of cardiac surgery, leading to increased in-hospital and long-term mortality rates. Many studies have suggested using statins protect against POAF. Thus, we aim investigate if statin pre-treatment may effectively lower the incidence Method: We performed systematic literature search PubMed for potential between January 2006 August 2021. Principal inclusion criteria were: randomized clinical trials...

10.22541/au.163655013.32285028/v1 preprint EN Authorea (Authorea) 2021-11-10

Abstract Background The Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria have been proposed to stratify the bleeding risk of patients undergoing percutaneous coronary intervention (PCI). While most were established, 4 on a de novo basis. Purpose We assessed prevalence and prognosis new ARC-HBR in contemporary, prospective, multicenter, quality-improvement registry all-comers with acute syndromes. Methods Between 2016 2020, consecutive subjects enrolled; baseline...

10.1093/eurheartj/ehab724.1415 article EN European Heart Journal 2021-10-01
Coming Soon ...